(Q44066450)

29 November 2017

title

Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan (English)

1 reference

29 November 2017

Eto M

1

1 reference

29 November 2017

Saito M

2

1 reference

29 November 2017

Nakata H

3

1 reference

29 November 2017

Iwashima Y

4

1 reference

29 November 2017

Watanabe K

5

1 reference

29 November 2017

Ikoda A

6

1 reference

29 November 2017

Kaku K

7

1 reference

29 November 2017

publication date

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

61

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

416-422

1 reference

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Apolipoprotein E phenotypes in hyperlipidaemic patients and their implications for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Type III Hyperlipoproteinemia: Diagnosis in Whole Plasma by Apolipoprotein-E Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Association of Apolipoprotein 2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

Apolipoprotein E alleles and hyperlipoproteinemia in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Triglyceride-rich lipoproteins from apolipoprotein E3/2 subjects with hypertriglyceridemia enhance cholesteryl ester synthesis in human macrophages

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Clinical features of type III hyperlipoproteinemia: analysis of 64 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Oxidative modification of glycated low density lipoprotein in the presence of iron

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610604.X

7 January 2021

10.1034/J.1399-0004.2002.610604.X

Identifiers

DOI

1 reference

release_jfp7b56wrza6netlgfz5cadnfu

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jfp7b56wrza6netlgfz5cadnfu

24 November 2022

mapped directly with Wikidata item

1 reference